Breaking: USPTO releases Section 101 report

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Breaking: USPTO releases Section 101 report

Kathi Vidal
Kathi Vidal

The patent office report found that stakeholders were still divided over subject matter eligibility but broadly wanted clarity

The USPTO released a report on the state of subject matter eligibility today, June 28.

The office said stakeholders across the spectrum agreed that US patent eligibility law, which is set out in Section 101 under Title 35 of the US Code, needed to be clearer, more predictable and consistently applied. It also confirmed that different stakeholders maintained different views on the matter.

The USPTO published the document in response to a request from senators Thom Tillis, Chris Coons, Mazie Hirono, and Tom Cotton in March 2021.

The senators had asked the office to publish a request for information on the current state of patent eligibility jurisprudence in the US, evaluate the responses, and provide them with a detailed summary of its findings.

The report showed that certain stakeholders supported the current state of Section 101 law because it helped them fight abusive and costly litigation involving software patents they felt were too broad.

Some life sciences and patient advocacy organisations also supported the US’s 101 framework because it bolstered access to medical technologies, the report stated.

The USPTO said in its report that other stakeholders were critical of the law because they felt it inhibited investment in new technologies and companies, especially in life sciences.

Some start-ups and small and medium-sized enterprises argued that Section 101 law as it stood lowered access to private risk capital and undermined innovation.

“Though these results were not surprising, the USPTO will continue to solicit feedback from stakeholders, including through listening sessions,” the report stated.

The topic of Section 101 gained traction in the US after the Supreme Court issued its rulings on Mayo, Myriad and Alice between 2012 and 2014. These edicts made it harder for companies to obtain diagnostics, gene sequencing, software and other related patents.

The Supreme Court is now deciding whether to hear American Axle v Neapco. In that case, the Court of Appeals for the Federal Circuit invalidated American Axle’s drive shaft patent on the basis that it was directed towards a law of nature.

Counsel previously told Managing IP that they hoped the report would drive legislative change on Section 101.

more from across site and SHARED ros bottom lb

More from across our site

This year’s IP STARS Americas rankings reveal that firms are expanding their capabilities, particularly in trade secrets and life sciences
Law firms’ expanding IP capabilities are driving broader industry recognition across a wider range of practice areas
As specialist boutiques challenge traditional firm models, major disputes involving Disney, Ericsson, Siemens and Dolby highlight the firms winning work before the UPC
The firm has added two leading damages specialists as it expands beyond technical analysis and deepens its role in the economics of IP litigation
Josh Seidenfeld, partner at DLA Piper, outlines the emerging legal trends that drive the future of life sciences innovation and how stakeholders can prepare for the future
South Korea's One Law Partners is combining with boutique firm Minwho Law Group to leverage global expansion of K-content and build a broader offering spanning IP, tech and regulatory advisory work
Russell Kennedy's Gina Tresidder on juggling matters, delivering hard truths, and why IP ownership is rarely as simple as people think
Attorney Oran Friar and trainee attorney Harry Cunliffe at Reddie & Grose, share that patent filings for clinical LLMs are surging, but success in the UK and Europe hinges on demonstrating technical innovation
Implementers can use the UK courts to seek FRAND terms for patent pool licences
The first credible UPC spinouts are growing, and they are coming from elite patent litigation teams, suggesting specialist litigators may no longer need large platforms to compete
Gift this article